speb/financial-data huggingface dataset:
CLMT cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -100000.00
CLMT cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: -62200000.00
CLMT income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 62200000.00
CLMT income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -7200000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -7000000.00
CLMT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 12100000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 282700000.00
CLMT income_statement (quarterly, 2025-03-31) — Gross Profit: -81400000.00
CLMT income_statement (quarterly, 2025-03-31) — Interest Expense: 58500000.00
CLMT income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 58500000.00
CLMT cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 60400000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Interest Payable: 36400000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Inventory: 389400000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1463800000.00
CLMT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 77800000.00
CLMT cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1746600000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 2302200000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2302200000.00
CLMT cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1746600000.00
CLMT cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1580000000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Minority Interest: 245600000.00
CLMT cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 95400000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Net Debt: 2202700000.00
CLMT income_statement (quarterly, 2025-03-31) — Net Income: -162000000.00
CLMT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -162000000.00
CLMT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -162000000.00
CLMT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -162000000.00
CLMT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -162000000.00
CLMT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -162000000.00
CLMT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -162000000.00
CLMT income_statement (quarterly, 2025-03-31) — Net Interest Income: -58500000.00
CLMT cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 166600000.00
CLMT cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 166600000.00
CLMT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -58500000.00
CLMT cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -57600000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Net PPE: 1412900000.00
CLMT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -17600000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -862300000.00
CLMT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -73500000.00
CLMT income_statement (quarterly, 2025-03-31) — Normalized Income: -167846000.00
CLMT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -29300000.00
CLMT cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -16600000.00
CLMT income_statement (quarterly, 2025-03-31) — Operating Income: -110900000.00
CLMT income_statement (quarterly, 2025-03-31) — Operating Revenue: 993900000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 86621470.00
CLMT balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 21900000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 457500000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -7000000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 7800000.00
CLMT income_statement (quarterly, 2025-03-31) — Other Gand A: 12100000.00
CLMT income_statement (quarterly, 2025-03-31) — Other Income Expense: 7800000.00
CLMT cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 136000000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 492800000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 269000000.00
CLMT income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 400000.00
CLMT income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 5100000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Other Receivables: 21800000.00
CLMT income_statement (quarterly, 2025-03-31) — Other Special Charges: 47600000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Payables: 306100000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 387700000.00
CLMT income_statement (quarterly, 2025-03-31) — Pretax Income: -161600000.00
CLMT cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -17600000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Raw Materials: 80500000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Receivables: 303200000.00
CLMT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1075300000.00
CLMT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 37000000.00
CLMT cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1580000000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 80000000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1701000000.00
CLMT cash_flow (quarterly, 2025-03-31) — Sale Of Business: 95400000.00
CLMT income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 12300000.00
CLMT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 24400000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Share Issued: 86621470.00
CLMT income_statement (quarterly, 2025-03-31) — Special Income Charges: 14600000.00
CLMT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: -21500000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -862300000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -862300000.00
CLMT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 1554000.00
CLMT income_statement (quarterly, 2025-03-31) — Tax Provision: 400000.00
CLMT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CLMT balance_sheet (quarterly, 2025-03-31) — Total Assets: 2823600000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1439900000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Total Debt: 2326100000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -616700000.00
CLMT income_statement (quarterly, 2025-03-31) — Total Expenses: 1104800000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3440300000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1905700000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2571200000.00
CLMT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -48700000.00
CLMT income_statement (quarterly, 2025-03-31) — Total Unusual Items: 7400000.00
CLMT income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 7400000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Work In Process: 99500000.00
CLMT balance_sheet (quarterly, 2025-03-31) — Working Capital: 48800000.00
CLMT income_statement (quarterly, 2025-06-30) — +Operating Expense: 57400000.00
CLMT income_statement (quarterly, 2025-06-30) — +Total Revenue: 1026600000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 279300000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 271100000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 837500000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -1300000.00
CLMT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 86797123.00
CLMT income_statement (quarterly, 2025-06-30) — Basic EPS: -1.70
CLMT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 203400000.00
CLMT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -13600000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 900000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 110600000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 110600000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Cash Financial: 110600000.00
CLMT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 2600000.00
CLMT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -13600000.00
CLMT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1800000.00
CLMT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -6000000.00
CLMT cash_flow (quarterly, 2025-06-30) — Changes In Cash: -12800000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Common Stock: 900000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -1009700000.00
CLMT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1070200000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 105500000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Current Assets: 895800000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Current Debt: 231800000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 231800000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1176000000.00
CLMT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 86797123.00
CLMT income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.70
CLMT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -147900000.00
CLMT income_statement (quarterly, 2025-06-30) — EBIT: -94800000.00
CLMT income_statement (quarterly, 2025-06-30) — EBITDA: -94800000.00
CLMT cash_flow (quarterly, 2025-06-30) — End Cash Position: 190600000.00
CLMT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 2600000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Finished Goods: 193200000.00
CLMT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -15400000.00
CLMT cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -7000000.00
CLMT income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 0.00
CLMT income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 4300000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -7000000.00
CLMT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 41100000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 272400000.00
CLMT income_statement (quarterly, 2025-06-30) — Gross Profit: -43600000.00
CLMT income_statement (quarterly, 2025-06-30) — Interest Expense: 52900000.00
CLMT income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 52900000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Interest Payable: 47700000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Inventory: 370500000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1327600000.00
CLMT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -13600000.00
CLMT cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 519500000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 2105500000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2105500000.00
CLMT cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 519500000.00
CLMT cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -514700000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Minority Interest: 245600000.00
CLMT cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
CLMT balance_sheet (quarterly, 2025-06-30) — Net Debt: 2226700000.00
CLMT income_statement (quarterly, 2025-06-30) — Net Income: -147900000.00
CLMT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -147900000.00
CLMT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -147900000.00
CLMT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -147900000.00
CLMT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -147900000.00
CLMT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -147900000.00
CLMT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -147900000.00
CLMT income_statement (quarterly, 2025-06-30) — Net Interest Income: -52900000.00
CLMT cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 4800000.00
CLMT cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 4800000.00
CLMT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -52900000.00
CLMT cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -2200000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Net PPE: 1387700000.00
CLMT cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -13600000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -1009700000.00
CLMT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -99000000.00
CLMT income_statement (quarterly, 2025-06-30) — Normalized Income: -151218000.00
CLMT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1800000.00
CLMT cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 9500000.00
CLMT income_statement (quarterly, 2025-06-30) — Operating Income: -101000000.00
CLMT income_statement (quarterly, 2025-06-30) — Operating Revenue: 1026600000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 86659413.00
CLMT balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 28800000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 559400000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -7000000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 7800000.00
CLMT income_statement (quarterly, 2025-06-30) — Other Gand A: 41100000.00
CLMT income_statement (quarterly, 2025-06-30) — Other Income Expense: 6200000.00
CLMT cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 158100000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 492900000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 259000000.00
CLMT income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 2000000.00
CLMT income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 4100000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Other Receivables: 34800000.00
CLMT income_statement (quarterly, 2025-06-30) — Other Special Charges: 100000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Payables: 279300000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 384800000.00
CLMT income_statement (quarterly, 2025-06-30) — Pretax Income: -147700000.00
CLMT cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -13600000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Raw Materials: 78600000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Receivables: 305900000.00
CLMT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1070200000.00
CLMT cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -514700000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 80000000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1848900000.00
CLMT cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
CLMT income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 12200000.00
CLMT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 53300000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Share Issued: 86659413.00
CLMT income_statement (quarterly, 2025-06-30) — Special Income Charges: -100000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -1009700000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -1009700000.00
CLMT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 882000.00
CLMT income_statement (quarterly, 2025-06-30) — Tax Provision: 200000.00
CLMT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CLMT balance_sheet (quarterly, 2025-06-30) — Total Assets: 2776400000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1095800000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Total Debt: 2337300000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -764100000.00
CLMT income_statement (quarterly, 2025-06-30) — Total Expenses: 1127600000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 3540500000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1880600000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2364500000.00
CLMT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -101000000.00
CLMT income_statement (quarterly, 2025-06-30) — Total Unusual Items: 4200000.00
CLMT income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 4200000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Work In Process: 98700000.00
CLMT balance_sheet (quarterly, 2025-06-30) — Working Capital: -280200000.00
CLMT income_statement (quarterly, 2025-09-30) — +Operating Expense: 44400000.00
CLMT income_statement (quarterly, 2025-09-30) — +Total Revenue: 1078000000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 298700000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 263900000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 838400000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -1200000.00
CLMT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 86901141.00
CLMT income_statement (quarterly, 2025-09-30) — Basic EPS: 3.61
CLMT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 190600000.00
CLMT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -8400000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 900000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 94600000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 94600000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Cash Financial: 94600000.00
CLMT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -31100000.00
CLMT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -8400000.00
CLMT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 23500000.00
CLMT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -45900000.00
CLMT cash_flow (quarterly, 2025-09-30) — Changes In Cash: -16000000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Common Stock: 900000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -695300000.00
CLMT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 704300000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 95000000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Current Assets: 880100000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Current Debt: 155200000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 155200000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 776300000.00
CLMT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 86901141.00
CLMT income_statement (quarterly, 2025-09-30) — Diluted EPS: 3.61
CLMT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 313400000.00
CLMT income_statement (quarterly, 2025-09-30) — EBIT: 325600000.00
CLMT income_statement (quarterly, 2025-09-30) — EBITDA: 325600000.00
CLMT cash_flow (quarterly, 2025-09-30) — End Cash Position: 174600000.00
CLMT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -31100000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Finished Goods: 220700000.00
CLMT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 15100000.00
CLMT cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -2000000.00
CLMT income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: -6400000.00
CLMT income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -1500000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -6900000.00
CLMT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 31400000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 265100000.00
CLMT income_statement (quarterly, 2025-09-30) — Gross Profit: 373700000.00
CLMT income_statement (quarterly, 2025-09-30) — Interest Expense: 53600000.00
CLMT income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 53600000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Interest Payable: 28900000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Inventory: 400100000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1607300000.00
CLMT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -8400000.00
CLMT cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 538700000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 2147400000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2147400000.00
CLMT cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 538700000.00
CLMT cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -659500000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Minority Interest: 245600000.00
CLMT cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CLMT balance_sheet (quarterly, 2025-09-30) — Net Debt: 2208000000.00
CLMT income_statement (quarterly, 2025-09-30) — Net Income: 313400000.00
CLMT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 313400000.00
CLMT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 313400000.00
CLMT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 313400000.00
CLMT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 313400000.00
CLMT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 313400000.00
CLMT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 313400000.00
CLMT income_statement (quarterly, 2025-09-30) — Net Interest Income: -53600000.00
CLMT cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -120800000.00
CLMT cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -120800000.00
CLMT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -53600000.00
CLMT cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 89700000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Net PPE: 1362000000.00
CLMT cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -8400000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -695300000.00
CLMT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 333000000.00
CLMT income_statement (quarterly, 2025-09-30) — Normalized Income: 319675200.00
CLMT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 23500000.00
CLMT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -2000000.00
CLMT income_statement (quarterly, 2025-09-30) — Operating Income: 329300000.00
CLMT income_statement (quarterly, 2025-09-30) — Operating Revenue: 1078000000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 86752229.00
CLMT balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 26700000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 227400000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -6900000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 7800000.00
CLMT income_statement (quarterly, 2025-09-30) — Other Gand A: 31400000.00
CLMT income_statement (quarterly, 2025-09-30) — Other Income Expense: -3700000.00
CLMT cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -242000000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 491800000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 259900000.00
CLMT income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 3700000.00
CLMT income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 2100000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Other Receivables: 14800000.00
CLMT income_statement (quarterly, 2025-09-30) — Other Special Charges: -500000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Payables: 298700000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 393700000.00
CLMT income_statement (quarterly, 2025-09-30) — Pretax Income: 272000000.00
CLMT cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -8400000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Raw Materials: 75200000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Receivables: 278700000.00
CLMT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 704300000.00
CLMT cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -659500000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 80000000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1535500000.00
CLMT cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
CLMT income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 10900000.00
CLMT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 42300000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Share Issued: 86752229.00
CLMT income_statement (quarterly, 2025-09-30) — Special Income Charges: -5900000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -695300000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -695300000.00
CLMT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1124800.00
CLMT income_statement (quarterly, 2025-09-30) — Tax Provision: -41400000.00
CLMT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
CLMT balance_sheet (quarterly, 2025-09-30) — Total Assets: 2733900000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1452100000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Total Debt: 2302600000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -449700000.00
CLMT income_statement (quarterly, 2025-09-30) — Total Expenses: 748700000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3183600000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1853800000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2407300000.00
CLMT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 322900000.00
CLMT income_statement (quarterly, 2025-09-30) — Total Unusual Items: -7400000.00
CLMT income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -7400000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Work In Process: 104200000.00
CLMT balance_sheet (quarterly, 2025-09-30) — Working Capital: 103800000.00
CLMT income_statement (annual, 2025-12-31) — +Operating Expense: 191500000.00
CLMT income_statement (quarterly, 2025-12-31) — +Operating Expense: 60200000.00
CLMT income_statement (annual, 2025-12-31) — +Total Revenue: 4137100000.00
CLMT income_statement (quarterly, 2025-12-31) — +Total Revenue: 1038600000.00
CLMT balance_sheet (annual, 2025-12-31) — Accounts Payable: 281500000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 281500000.00
CLMT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 224400000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 224400000.00
CLMT balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1342500000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1342500000.00
CLMT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 838800000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 838800000.00
CLMT balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1100000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1100000.00
CLMT cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 1300000.00
CLMT income_statement (annual, 2025-12-31) — Basic Average Shares: 86761139.00
CLMT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 86910580.00
CLMT income_statement (annual, 2025-12-31) — Basic EPS: -0.39
CLMT income_statement (quarterly, 2025-12-31) — Basic EPS: -0.43
CLMT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 45900000.00
CLMT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 174600000.00
CLMT balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 41600000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 41600000.00
CLMT cash_flow (annual, 2025-12-31) — Capital Expenditure: -52300000.00
CLMT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -12700000.00
CLMT balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 225600000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 225600000.00
CLMT balance_sheet (annual, 2025-12-31) — Capital Stock: 900000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 900000.00
CLMT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 125100000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 125100000.00
CLMT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 125100000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 125100000.00
CLMT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 6200000.00
CLMT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -74300000.00
CLMT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 44100000.00
CLMT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11700000.00
CLMT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 108900000.00
CLMT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 116500000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Account Payable: -52200000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 15300000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 5700000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Interest Payable: 700000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Inventory: 14900000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -2600000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -4700000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Payable: -46500000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -31200000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -2100000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Receivables: 47000000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Tax Payable: 5700000.00
CLMT cash_flow (annual, 2025-12-31) — Change In Working Capital: 21300000.00
CLMT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 75400000.00
CLMT cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 47000000.00
CLMT cash_flow (annual, 2025-12-31) — Changes In Cash: 159200000.00
CLMT cash_flow (quarterly, 2025-12-31) — Changes In Cash: 30500000.00
CLMT balance_sheet (annual, 2025-12-31) — Common Stock: 900000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Common Stock: 900000.00
CLMT balance_sheet (annual, 2025-12-31) — Common Stock Equity: -732700000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -732700000.00
CLMT balance_sheet (annual, 2025-12-31) — Construction In Progress: 76600000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 76600000.00
CLMT income_statement (annual, 2025-12-31) — Cost Of Revenue: 3891400000.00
CLMT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1041600000.00
CLMT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 130700000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 130700000.00
CLMT balance_sheet (annual, 2025-12-31) — Current Assets: 857800000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Current Assets: 857800000.00
CLMT balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 64200000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 64200000.00
CLMT balance_sheet (annual, 2025-12-31) — Current Debt: 156200000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Current Debt: 156200000.00
CLMT balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 220400000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 220400000.00
CLMT balance_sheet (annual, 2025-12-31) — Current Liabilities: 840700000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 840700000.00
CLMT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 148800000.00
CLMT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 148800000.00
CLMT income_statement (annual, 2025-12-31) — Diluted Average Shares: 86761139.00
CLMT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 86910580.00
CLMT income_statement (annual, 2025-12-31) — Diluted EPS: -0.39
CLMT income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.43
CLMT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -33800000.00
CLMT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -37300000.00
CLMT income_statement (annual, 2025-12-31) — EBIT: 89400000.00
CLMT income_statement (quarterly, 2025-12-31) — EBIT: -38300000.00
CLMT income_statement (annual, 2025-12-31) — EBITDA: 238200000.00
CLMT income_statement (quarterly, 2025-12-31) — EBITDA: -38300000.00
CLMT balance_sheet (annual, 2025-12-31) — Employee Benefits: 3800000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 3800000.00
CLMT cash_flow (annual, 2025-12-31) — End Cash Position: 205100000.00
CLMT cash_flow (quarterly, 2025-12-31) — End Cash Position: 205100000.00
CLMT cash_flow (annual, 2025-12-31) — Financing Cash Flow: 6200000.00
CLMT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -74300000.00
CLMT balance_sheet (annual, 2025-12-31) — Finished Goods: 216300000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Finished Goods: 216300000.00
CLMT cash_flow (annual, 2025-12-31) — Free Cash Flow: 56600000.00
CLMT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 103800000.00
CLMT cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -24100000.00
CLMT cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -15000000.00
CLMT cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -55800000.00
CLMT income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 55800000.00
CLMT income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 0.00
CLMT income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 8700000.00
CLMT income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 13100000.00
CLMT balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -6800000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -6800000.00
CLMT income_statement (annual, 2025-12-31) — General And Administrative Expense: 123800000.00
CLMT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 39200000.00
CLMT balance_sheet (annual, 2025-12-31) — Goodwill: 140500000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Goodwill: 140500000.00
CLMT balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 149200000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 149200000.00
CLMT balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 225500000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 225500000.00
CLMT balance_sheet (annual, 2025-12-31) — Gross PPE: 2919700000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2919700000.00
CLMT income_statement (annual, 2025-12-31) — Gross Profit: 245700000.00
CLMT income_statement (quarterly, 2025-12-31) — Gross Profit: -3000000.00
CLMT balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 6700000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 6700000.00
CLMT income_statement (annual, 2025-12-31) — Interest Expense: 215800000.00
CLMT income_statement (quarterly, 2025-12-31) — Interest Expense: 50800000.00
CLMT income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 215800000.00
CLMT income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 50800000.00
CLMT cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 172400000.00
CLMT cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 21500000.00
CLMT balance_sheet (annual, 2025-12-31) — Interest Payable: 46100000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Interest Payable: 46100000.00
CLMT balance_sheet (annual, 2025-12-31) — Inventory: 385200000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Inventory: 385200000.00
CLMT balance_sheet (annual, 2025-12-31) — Invested Capital: 1500800000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1500800000.00
CLMT cash_flow (annual, 2025-12-31) — Investing Cash Flow: 44100000.00
CLMT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -11700000.00
CLMT cash_flow (annual, 2025-12-31) — Issuance Of Debt: 3219800000.00
CLMT cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 415000000.00
CLMT balance_sheet (annual, 2025-12-31) — Land And Improvements: 10400000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 10400000.00
CLMT balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 161400000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 161400000.00
CLMT balance_sheet (annual, 2025-12-31) — Long Term Debt: 2077300000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 2077300000.00
CLMT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2238700000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2238700000.00
CLMT cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3219800000.00
CLMT cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 415000000.00
CLMT cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -3243300000.00
CLMT cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -489100000.00
CLMT balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2560000000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2560000000.00
CLMT balance_sheet (annual, 2025-12-31) — Minority Interest: 245600000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Minority Interest: 245600000.00
CLMT cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 96900000.00
CLMT cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 1500000.00
CLMT balance_sheet (annual, 2025-12-31) — Net Debt: 2108400000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Net Debt: 2108400000.00
CLMT income_statement (annual, 2025-12-31) — Net Income: -33800000.00
CLMT income_statement (quarterly, 2025-12-31) — Net Income: -37300000.00
CLMT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -33800000.00
CLMT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -37300000.00
CLMT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -33800000.00
CLMT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -37300000.00
CLMT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -33800000.00
CLMT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -37300000.00
CLMT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -33800000.00
CLMT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -37300000.00
CLMT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -33800000.00
CLMT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -37300000.00
CLMT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -33800000.00
CLMT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -37300000.00
CLMT income_statement (annual, 2025-12-31) — Net Interest Income: -215800000.00
CLMT income_statement (quarterly, 2025-12-31) — Net Interest Income: -50800000.00
CLMT cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -500000.00
CLMT cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -23500000.00
CLMT cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -74100000.00
CLMT cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -23500000.00
CLMT cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -74100000.00
CLMT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -215800000.00
CLMT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -50800000.00
CLMT cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 29700000.00
CLMT cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -200000.00
CLMT balance_sheet (annual, 2025-12-31) — Net PPE: 1577200000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Net PPE: 1577200000.00
CLMT cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -52300000.00
CLMT cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -12700000.00
CLMT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -881900000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -881900000.00
CLMT balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3800000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3800000.00
CLMT income_statement (annual, 2025-12-31) — Normalized EBITDA: 222400000.00
CLMT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -49900000.00
CLMT income_statement (annual, 2025-12-31) — Normalized Income: -46282000.00
CLMT income_statement (quarterly, 2025-12-31) — Normalized Income: -46464000.00
CLMT cash_flow (annual, 2025-12-31) — Operating Cash Flow: 108900000.00
CLMT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 116500000.00
CLMT cash_flow (annual, 2025-12-31) — Operating Gains Losses: -32500000.00
CLMT cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -23400000.00
CLMT income_statement (annual, 2025-12-31) — Operating Income: 54200000.00
CLMT income_statement (quarterly, 2025-12-31) — Operating Income: -63200000.00
CLMT income_statement (annual, 2025-12-31) — Operating Revenue: 4137100000.00
CLMT income_statement (quarterly, 2025-12-31) — Operating Revenue: 1038600000.00
CLMT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 86776552.00
CLMT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 86776552.00
CLMT balance_sheet (annual, 2025-12-31) — Other Current Assets: 28300000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 28300000.00
CLMT balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 156200000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 156200000.00
CLMT balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 190400000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 190400000.00
CLMT balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -6800000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -6800000.00
CLMT balance_sheet (annual, 2025-12-31) — Other Equity Interest: 7800000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 7800000.00
CLMT income_statement (annual, 2025-12-31) — Other Gand A: 123800000.00
CLMT income_statement (quarterly, 2025-12-31) — Other Gand A: 39200000.00
CLMT income_statement (annual, 2025-12-31) — Other Income Expense: 35200000.00
CLMT income_statement (quarterly, 2025-12-31) — Other Income Expense: 24900000.00
CLMT balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 8700000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 8700000.00
CLMT cash_flow (annual, 2025-12-31) — Other Non Cash Items: 8300000.00
CLMT cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -43800000.00
CLMT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 104700000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 104700000.00
CLMT balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 92800000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 92800000.00
CLMT income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 19400000.00
CLMT income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 13300000.00
CLMT balance_sheet (annual, 2025-12-31) — Other Properties: 231100000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Other Properties: 231100000.00
CLMT balance_sheet (annual, 2025-12-31) — Other Receivables: 8100000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Other Receivables: 8100000.00
CLMT income_statement (annual, 2025-12-31) — Other Special Charges: 47400000.00
CLMT income_statement (quarterly, 2025-12-31) — Other Special Charges: 200000.00
CLMT income_statement (annual, 2025-12-31) — Other Taxes: 19800000.00
CLMT balance_sheet (annual, 2025-12-31) — Payables: 299200000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Payables: 299200000.00
CLMT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 429900000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 429900000.00
CLMT income_statement (annual, 2025-12-31) — Pretax Income: -126400000.00
CLMT income_statement (quarterly, 2025-12-31) — Pretax Income: -89100000.00
CLMT balance_sheet (annual, 2025-12-31) — Properties: 0.00
CLMT balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CLMT cash_flow (annual, 2025-12-31) — Purchase Of Investment: -500000.00
CLMT cash_flow (annual, 2025-12-31) — Purchase Of PPE: -52300000.00
CLMT cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -12700000.00
CLMT balance_sheet (annual, 2025-12-31) — Raw Materials: 67500000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Raw Materials: 67500000.00
CLMT balance_sheet (annual, 2025-12-31) — Receivables: 232500000.00
CLMT balance_sheet (quarterly, 2025-12-31) — Receivables: 232500000.00
CLMT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 3891400000.00
CLMT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1041600000.00
CLMT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 148800000.00
CLMT cash_flow (annual, 2025-12-31) — Repayment Of Debt: -3243300000.00
CLMT cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -489100000.00
CLMT balance_sheet (annual, 2025-12-31) — Restricted Cash: 80000000.00